52 116

Cited 3 times in

KASL clinical practice guidelines for management of autoimmune hepatitis 2022

DC Field Value Language
dc.contributor.author김자경-
dc.contributor.author이현웅-
dc.date.accessioned2024-01-03T00:30:53Z-
dc.date.available2024-01-03T00:30:53Z-
dc.date.issued2023-07-
dc.identifier.issn2287-2728-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/197276-
dc.description.abstract[No abstract available]-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherKorean Association for the Study of the Liver-
dc.relation.isPartOfCLINICAL AND MOLECULAR HEPATOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHAntiviral Agents-
dc.subject.MESHHepatitis, Autoimmune* / diagnosis-
dc.subject.MESHHepatitis, Autoimmune* / drug therapy-
dc.subject.MESHHumans-
dc.subject.MESHLiver Cirrhosis-
dc.titleKASL clinical practice guidelines for management of autoimmune hepatitis 2022-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorKorean Association for the Study of the Liver (KASL)-
dc.identifier.doi10.3350/cmh.2023.0087-
dc.contributor.localIdA00852-
dc.contributor.localIdA03292-
dc.relation.journalcodeJ00557-
dc.identifier.eissn2287-285X-
dc.identifier.pmid37137334-
dc.contributor.alternativeNameKim, Ja Kyung-
dc.contributor.affiliatedAuthor김자경-
dc.contributor.affiliatedAuthor이현웅-
dc.citation.volume29-
dc.citation.number3-
dc.citation.startPage542-
dc.citation.endPage592-
dc.identifier.bibliographicCitationCLINICAL AND MOLECULAR HEPATOLOGY, Vol.29(3) : 542-592, 2023-07-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.